Recent Updates
Recently added Catalysts
HAE Positive Sentiment

Haemonetics Corporation Announces Third Quarter Fiscal 2026 Financial Results Available on Investor Relations Website Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2026, which ended December 27, 2025, are...

Key Takeaway: Haemonetics Corporation has announced the availability of its financial results for the third quarter of fiscal year 2026, which concluded on December 27, 2025. The results can be accessed on the Company's Investor Relations website. A conference call and webcast will be held on February 5, 2026, to discuss these results with investors and analysts.
Price reaction · baseline $65.95 (2026-02-04 close) · hit after-hours · 1 other HAE headline(s) in the window, move may be shared
day 0 close
-1.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Haemonetics reported its third quarter fiscal 2026 financial results.
  • The company is hosting a conference call to discuss the results.
  • Earnings materials are available for investors to review.

Full Press Release Details

Financial release and supplemental presentation accessible online
BOSTON , Feb. 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that financial results for its third quarter fiscal year 2026, which ended December 27, 2025, are available on the Company's Investor Relations website at www.haemonetics.com .
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on February 5, 2026.
Conference Call and Webcast Information:
• Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
• Live webcast: Access here or through the Investor Relations section of the Haemonetics website.
A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on February 5, 2026 and will remain accessible for one year via the webcast link above.
Earnings Materials: Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:
• Third Quarter Fiscal 2026 Earnings Release
• Third Quarter Fiscal 2026 Supplemental Earnings Presentation
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com .
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
David Trenk, Manager-Investor Relations
(781) 356-9763
(203) 733-4987
[email protected]
[email protected]
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
[email protected]

Frequently Asked Questions

When are Haemonetics' Q3 fiscal 2026 results available?

The financial results for Q3 fiscal 2026 are available on Haemonetics' Investor Relations website.

What time is the conference call for Q3 results?

The conference call will take place at 8:00 a.m. ET on February 5, 2026.

How can I access the conference call?

Participants can register online to receive dial-in details and a personalized PIN.

Will there be a replay of the conference call?

Yes, a replay will be available starting at 11:00 a.m. ET on February 5, 2026.

Last updated: Feb 5, 2026